WebSep 13, 2024 · The authors describe the CMA’s assessment of the gap between... Davies and Padilla examine the UK Competition and Markets Authority’s 2016 decision to … WebJun 7, 2024 · Judgment of the Tribunal in relation to two appeals against a decision of the Competition and Markets Authority (“CMA”) entitled “Unfair pricing in respect …
CMA to reassess price fairness of epilepsy drug - Pinsent Masons
21 July 2024: The CMA has found competition law breaches in relation to the supply of phenytoin sodium capsules in the UK. 1. Press release: £70 million in fines for pharma firms that overcharged NHS(21.7.22) See more 21 February 2024: The CMA has published a non-confidential version of the decision in this case. 1. Non-confidential decision (PDF, 3.93 MB)(21.2.23) 2. Annexes (PDF, 1.65 … See more 10 March 2024: The Court of Appeal has today handed down its judgment partially allowing the CMA’s appeal and dismissing Flynn’s appeal in its … See more 5 August 2024: Following the Court of Appeal’s judgment, the CMA decided to re-investigate the matters remitted by the CAT, and opened its current investigation in June 2024. Having reconsidered these matters, on 5 August … See more 12 April 2016: The CMA has published a notice of a penalty imposed on Pfizer under section 40A of the CA98. The CMA imposed the penalty on 31 March 2016 for a failure to comply, without reasonable excuse, with a … See more WebOn 7 June 2024, the Competition Appeal Tribunal (CAT) set aside in part the 2016 decision of the Competition and Markets Authority (CMA) that Pfizer and Flynn Pharma had abused their dominant positions by setting excessive and unfair prices for the capsule form of the epilepsy drug phenytoin sodium. 1 The CAT, in reaching this conclusion, concluded that … definition of redundantly
Case details - Supreme Court of the United Kingdom
WebApr 2, 2024 · The Phenytoin decision was the CMA’s first in this area,3 but at the time it was made, it had opened two further excessive pricing investigations in relation to the phar-maceutical sector.4 Both Pfizer and Flynn appealed to the CAT, and in June 2024 the CAT found that both held dominant posi-tions but, finding that the CMA had erred in a number WebJun 11, 2024 · The CMA's decision relied on a comparison between cost and price to determine whether the prices were excessive. The decision was based on an abstract analysis, which compared the price with a ... WebOn 10 March 2024, the Court of Appeal dismissed the Competition and Markets Authority's ("CMA") appeal against a previous decision of the Competition Appeal Tribunal on … definition of reede